Published Date: 23 Apr 2023
The treatment of chronic thromboembolic pulmonary hypertension with balloon pulmonary angioplasty has an evolving safety profile over the years, from 2013 to 2022, as revealed by an analysis of more than two dozen studies.
Read Full News1.
Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.
2.
Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.
3.
FDA approves Blenrep for relapsed or refractory multiple myeloma
4.
Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.
5.
Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC
1.
Understanding Iron Saturation Levels in Your Blood
2.
Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges
3.
Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies
4.
How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?
5.
Unveiling the Mystery of Castleman's Disease: A Journey to Better Health
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
4.
Navigating the Complexities of Ph Negative ALL - Part XIV
5.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation